The importance of orthostatic intolerance in the chronic fatigue syndrome

American Journal of the Medical Sciences

Volumn 317, Issue 2, 1999, Pages 117-123

  Schondorf, Ronald ^a,c   Freeman, Roy ^b  

^a MCGILL UNIVERSITY   (Canada)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic fatigue syndrome; Dysautonomia; Orthostatic intolerance; Syncope; Tachycardia

Indexed keywords

CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; TACHYCARDIA;

EID: 0032736924     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199902000-00006     Document Type: Conference Paper

References (87)

1. Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996;101:281-90.
2. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
3. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993;153:2759-65.
4. Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. In: Bock GR, Whelan J, editors. Chronic fatigue syndrome. Ciba Foundation Symposium Series, vol. 173. Chichester: John Wiley & Sons; 1993. p. 23-42.
5. Gunn WJ, Connell DB, Randall B. Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study. In: Bock GR, Whelan J, editors. Chronic fatigue syndrome. Ciba Foundation Symposium Series, vol. 173. Chichester: John Wiley & Sons; 1993. p. 83-93.
6. Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995;17:139-51.
7. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990;150:1685-9.
8. Komaroff AL. Minor illness symptoms: the magnitude of their burden and of our ignorance. Arch Intern Med 1990;150: 1586-7.
9. Hickie I, Lloyd A, Hadzi PD, et al. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995;25:925-35.
10. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-9.
11. Rogers MP, Chang G. Psychiatric aspects. In: Dawson DM, Sabin TD, editors. Chronic fatigue syndrome. Boston: Little Brown; 1993. p. 45-68.
12. Tiersky LA, Johnson SK, Lange G, et al. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol 1997;19:560-86.
13. Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87: 1449-55.
14. Komaroff AL. Experience with sporadic and epidemic cases. In: Dawson DM, Sabin TD, editors. Chronic fatigue syndrome. Boston: Little Brown 1993. p. 25-43.
15. Komaroff AL. Clinical presentation of chronic fatigue syndrome. In: Bock GR, Whelan J, editors. Chronic fatigue syndrome. Ciba Foundation Symposium Series, vol. 173. Chichester: John Wiley & Sons 1993. p. 43-61.
16. MacDonald KL, Osterholm MT, LeDell KH, et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med 1996;100:548-54.
17. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med 1997;90:223-33.
18. Bombardier CH, Buchwald D. Outcome and prognosis of patients with chronic fatigue vs chronic fatigue syndrome. Arch Intern Med 1995;155:2105-10.
19. Vercoulen J, Swanink C, Fennis J, et al. Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatry 1996;60:489-94.
20. Blomqvist CG, Stone HL. Cardiovascular adjustments to gravitational stress. Handbook of physiology. The cardiovascular system. Peripheral circulation and organ blood flow. Bethesda: American Physiological Society; 1983. p. 1025-63.
21. Rowell LB. Human cardiovascular control. New York: Oxford University Press; 1993.
22. Rowell LB, Detry JMR, Blackmon JR, et al. Importance of the splanchnic vascular bed in human blood pressure. J Appl Physiol 1972;32:213-20.
23. Johnson JM, Rowell LB, Niederberger M, et al. Human splanchnic and forearm vasoconstrictor responses to reductions of right atrial and aortic pressure. Circ Res 1974;34: 515-24.
24. Lundvall J, Edfeldt H. Much more potent baroreflex sympathetic control of vascular resistance in the resting human limb than previously believed. Acta Physiol Scand 1993;147: 185-93.
25. Lundvall J, Edfeldt H. Very large range of baroreflex sympathetic control of vascular resistance in human skeletal muscle and skin. J Appl Physiol 1994;76:204-11.
26. Low PA, Schondorf R, Novak V, et al. Postural tachycardia syndrome (POTS). In: Low PA, editors. Clinical autonomic disorders. 2nd ed. Philadelphia: Lippincott-Raven; 1997. p. 681-97.
27. Low PA, Opfer-Gehrking TL, McPhee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:17-622.
28. Streeten DHP. Orthostatic disorders of the circulation: mechanisms, manifestations and treatment. New York: Plenum Medical Book Company; 1987.
29. Streeten DHP, Andersen GH. Delayed orthostatic intolerance. Arch Intern Med 1992;152:1066-72.
30. Rowe PC, Bou-Holaigah I, Kan JS, et al. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995;345:623-4.
31. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993;43:132-7.
32. Low PA, Opfer-Gehrking TL, Textor SC, et al. Postural tachycardia syndrome (POTS). Neurology 1995;45:S19-S25.
33. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997;102:357-64.
34. Schondorf R, Wein T, Phaneuf D. Orthostatic intolerance in patients with chronic fatigue syndrome. Clin Auton Res 1995;5:320.
35. Bou-Holaigah I, Rowe PC, Kan J, et al. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995;274:961-7.
36. De Lorenzo F, Hargreaves J, Kakkar VV. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clin Auton Res 1997; 7:185-90.
37. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-51.
38. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol 1996;28:263-75.
39. Novak V, Honos G, Schondorf R. Is the heart 'empty' at syncope? J Auton Nerv Syst 1996;60:83-92.
40. Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, et al. Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 1997;99: 2736-44.
41. Hainsworth R. Reflexes from the heart. Physiol Rev 1991; 71:617-58.
42. Fitzpatrick AP, Banner N, Cheng A, et al. Vasovagal reactions may occur after orthotopic heart transplantation. J Am Coll Cardiol 1993;21:1132-7.
43. Lightfoot JT, Rowe SA, Fortney SM. Occurrence of presyncope in subjects without ventricular innervation. Clin Sci (Colch) 1993;85:695-700.
44. Ludbrook J, Ventura S. Roles of carotid baroreceptor and cardiac afferents in hemodynamic responses to acute central hypovolemia. Am J Physiol 1996;270:H1538-48.
45. de Jong-Vos van Steenwijk CCE, Wieling W, Johannes JM, et al. Incidence and hemodynamic characteristics of near-fainting in healthy 6-to 16-year old subjects. J Am Coll Cardiol 1995;25:1615-21.
46. Steven PM. Cardiovascular dynamics during orthostasis and influence of intravascular instrumentation. Am J Cardiol 1966;17:211-8.
47. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Int Med 1992;116:358-63.
48. Pohl R, Yeragani VK, Balon R, et al. Isoproterenol-induced panic attacks. Biol Psych 1988;24:891-902.
49. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994;97:78-88.
50. Jacob G, Shannon JR, Black B, et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997;96:575-80.
51. De Lorenzo F, Hargreaves J, Kakkar VV. Possible relationship between chronic fatigue and postural tachycardia syndromes. Clin Auton Res 1996;6:263-4.
52. Benditt DG. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pacing Clin Electrophysiol 1997;20:572-84.
53. Schondorf R, Benoit J, Wein T. Cerebrovascular and cardiovascular measurements during neurally mediated syncope induced by head-up tilt. Stroke 1997;28:1564-8.
54. Thomson HL, Wright K, Frenneaux M. Baroreflex sensitivity in patients with vasovagal syncope. Circulation 1997; 95:395-400.
55. Jacob G, Robertson D, Mosqueda-Garcia R, et al. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 1997;103:128-33.
56. Streeten DH. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest 1990;86:1582-8.
57. Thomson HL, Lele SS, Atherton JJ, et al. Abnormal forearm vascular responses during dynamic leg exercise in patients with vasovagal syncope. Circulation 1995;92: 2204-9.
58. Thomson HL, Atherton JJ, Khafagi FA, et al. Failure of reflex venoconstriction during exercise in patients with vasovagal syncope. Circulation 1996;93:953-9.
59. Sisto SA, Tapp W, Drastal S, et al. Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome. Clin Auton Res 1995;5:139-43.
60. Pagani M, Lucini D, Mela GS, et al. Sympathetic overactivity in subjects complaining of unexplained fatigue. Clin Sci 1994;87:655-61.
61. Soetekouw PMMB, Lenders JWM, Blijenberg G, et al. Autonomic function testing in patients with the chronic fatigue syndrome. Clin Auton Res 1997;7:236-7.
62. Suarez GA, Fealey RD, Camilleri M, et al. Idiopathic autonomic neuropathy: clinical, neurophysiological, and follow-up studies on 27 patients. Neurology 1994;44:1675-82.
63. Low PA. Autonomic neuropathies. Curr Opin Neurol 1994; 7:402-6.
64. Convertino VA. Conditions of reduced gravity. In: Low PA, ed. Clinical autonomic disorders. Philadelphia: Lippincott-Raven; 1997. p. 429-40.
65. Robertson D, Convertino VA, Vernikos J. The sympathetic nervous system and the physiologic consequences of spaceflight: a hypothesis. Am J Med Sci 1994;308:126-32.
66. Eckberg DL, Fritsch JM. Influence of ten-day head-down bedrest on human carotid baroreceptor-cardiac reflex function. Acta Physiol Scand 1992;604:69-76.
67. Convertino VA, Doerr DF, Eckberg DL, et al. Head-down bed rest impairs vagal baroreflex responses and provokes orthostatic hypotension. J Appl Physiol 1990;68:1458-64.
68. Convertino VA, Doerr DF, Stein SL. Changes in size and compliance of the calf after 30 days of simulated microgravity. J Appl Physiol 1989;66:1509-12.
69. Melchior FM, Fortney SM. Orthostatic intolerance during a 13-day bed rest does not result from increased leg compliance. J Appl Physiol 1993;74:286-92.
70. Bonde-Petersen F, Suzuki Y, Kawakubo K, et al. Effect of 20 days bed rest upon peripheral capillary filtration rate venous compliance and blood flow in arms and legs. Acta Physiol Scand 1994;150(suppl. 616):65-9.
71. Haruna Y, Suzuki Y, Kawakubo K, et al. Orthostatic tolerance and autonomous nervous functions before and after 20-days bed rest. Acta Physiol Scand 1994;616:71-81.
72. Levine BD, Zuckerman JH, Pawelczyk JA. Cardiac atrophy after bed-rest deconditioning - A nonneural mechanism for orthostatic intolerance. Circulation 1997;96:517-25.
73. Pavy-Le Traon A, Sigaudo D, Vasseur P, et al. Orthostatic tests after a 4-day confinement or simulated weightlessness. Clin Physiol 1997;17:41-55.
74. Ludwig DA, Convertino VA. Predicting orthostatic intolerance: physics or physiology? Aviat Space Environ Med 1994;65:404-11.
75. Franke WD, Taylor KA. Exercise training mode affects the hemodynamic responses to lower body negative pressure in women. Eur J Appl Physiol 1996;73:169-74.
76. Gibson H, Carroll N, Clague JE, et al. Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993;56:993-8.
77. Sisto SA, LaManca J, Cordero DL, et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. Am J Med 1996;100: 634-40.
78. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br Med J 1997;314:1647-52.
79. McCully KK, Sisto SA, Natelson BH. Use of exercise for treatment of chronic fatigue syndrome. Sports Med 1996;21: 35-48.
80. Greenleaf JE, Wade CE, Leftheriotis G. Orthostatic responses following 30-day bed rest deconditioning with isotonic and isokinetic exercise training. Aviat Space Environ Med 1989;60:537-42.
81. Greenleaf JE. Intensive exercise training during bed rest attenuates deconditioning. Med Sci Sports Exerc 1997;29: 207-15.
82. Rose BD. Clinical physiology of acid-base and electrolyte disorders. New York: McGraw-Hill; 1989.
83. Mion D Jr, Rea RF, Anderson EA, et al. Effects of fludrocortisone on sympathetic nerve activity in humans. Hypertension 1994;23:123-30.
84. Robertson D, Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995;45:S26-S32.
85. McTavish D, Goa KL. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 1989;38: 757-77.
86. Iwase S, Mano T, Saito M, et al. Long-acting alpha 1-adrenoceptive sympathomimetic agent suppresses sympathetic outflow to muscles in humans. J Auton Nerv Syst 1991;36:193-9.
87. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res 1993;3:57-65.